The increasing occurrence of kidney disorders worldwide
and the healthcare sector's increased focus on consistent
monitoring and effective management of these conditions are
expected to drive the demand for urine output monitoring systems
between 2024 and 2030.
LAS VEGAS, April 25, 2024 /PRNewswire/ --
DelveInsight's Urine Output Monitoring Systems Market
Insights report provides the current and forecast market
analysis, individual leading urine output monitoring systems
companies' market shares, challenges, urine output monitoring
systems market drivers, barriers, trends, and key market urine
output monitoring systems companies in the market.
Key Takeaways from the Urine Output Monitoring Systems Market
Report
- As per DelveInsight estimates, North
America is anticipated to dominate the global Urine Output
Monitoring Systems market during the forecast period.
- Notable urine output monitoring systems companies such as
BD, Potrero Medical Inc., 3i Group plc, Serenno Medical,
RenalSense Ltd., FIZE Medical, and several others, are
currently operating in the urine output monitoring systems
market.
- In February 2020, Serenno
Medical introduced the Sentinel device for continuous automatic
monitoring and detection of kidney damage in hospitalized
patients.
- In August 2019, RenalSense
received the CE Mark for its Clarity RMS, a critical care
monitoring platform that constantly measures a patient's urine
flow.
To read more about the latest highlights related to the urine
output monitoring systems market, get a snapshot of the key
highlights entailed in the Global Urine Output Monitoring
Systems Market Report
Urine Output Monitoring Systems Overview
Urine output monitoring systems play a crucial role in
healthcare settings, offering real-time insights into a patient's
renal function and overall health status. These systems typically
employ advanced technology to accurately measure and record urine
volume, allowing healthcare professionals to closely monitor fluid
balance, kidney function, and response to treatment. By providing
continuous, non-invasive monitoring, these systems aid in the early
detection of potential complications such as dehydration, renal
failure, or fluid overload, enabling timely interventions and
improved patient outcomes.
Furthermore, urine output monitoring systems streamline clinical
workflows by automating data collection and analysis, reducing the
burden on healthcare staff and minimizing the risk of human error.
With customizable alerts and integrated data management
capabilities, these systems empower healthcare teams to make
informed decisions based on real-time urine output data, enhancing
patient safety and optimizing resource utilization. In essence,
urine output monitoring systems serve as invaluable tools in modern
healthcare, facilitating proactive care management and ensuring
patients receive the personalized attention they need.
Urine Output Monitoring Systems Market Insights
In 2023, North America
dominated the urine output monitoring systems market due to various
factors such as a growing number of individuals with kidney
disorders, increased health awareness, rising disposable incomes,
the presence of key industry players, and ongoing product
development initiatives. These factors indicate a promising outlook
for the urine output monitoring systems market in the region
throughout the forecast period.
According to the Centers for Disease Control and Prevention
(CDC) in 2023, an estimated 35.5 million people, constituting more
than 1 in 7 US adults, were believed to have chronic kidney disease
(CKD) in 2021. Alarmingly, the CDC reported that as many as 9 out
of 10 adults with CKD in the US were unaware of their condition,
with approximately 1 in 3 adults having severe CKD being
undiagnosed.
Additionally, the increasing prevalence of diabetes, a
significant risk factor for kidney disorders, further drives the
demand for urine output monitoring systems in the United States. For instance, the CDC
reported in 2021 that around 28.7 million people in the US were
diagnosed with diabetes in 2019. Moreover, CDC data from 2022
revealed that approximately 96 million people in the US had
prediabetic conditions in 2019, further underlining the importance
of monitoring and managing kidney health in the region.
To know more about why North
America is leading the market growth in the urine output
monitoring systems market, get a snapshot of the Urine Output
Monitoring Systems Market Outlook
Urine Output Monitoring Systems Market Dynamics
The urine output monitoring systems market dynamics are
witnessing significant evolution driven by several factors. With
the rising prevalence of renal disorders, urinary tract
infections, and chronic diseases, there's a growing demand for
advanced monitoring systems to accurately measure and analyze urine
output. Additionally, the increasing adoption of these
systems in critical care settings, such as intensive care units
(ICUs) and operating rooms, is fueling urine output monitoring
systems market growth. Healthcare facilities are increasingly
recognizing the importance of precise urine output
monitoring in managing patient hydration levels, kidney
function, and overall health outcomes.
Furthermore, technological advancements play a crucial
role in shaping the urine output monitoring systems market
landscape. Innovations such as non-invasive monitoring techniques,
integration of wireless connectivity for real-time data
transmission, and the development of portable and wearable
devices are enhancing the efficiency and usability of these
systems. Moreover, the integration of artificial intelligence
(AI) and machine learning algorithms into urine output
monitoring platforms enables predictive analytics, early detection
of abnormalities, and personalized patient care, driving market
expansion and fostering a shift towards proactive healthcare
management strategies.
Moreover, regulatory initiatives and healthcare reforms
are influencing urine output monitoring systems market dynamics by
setting standards for product safety, performance, and
interoperability. Compliance with stringent regulatory guidelines,
such as those set forth by the FDA and other regulatory bodies, is
imperative for manufacturers to ensure product quality and market
acceptance. Additionally, reimbursement policies and
incentives for healthcare providers investing in advanced
monitoring technologies are shaping purchasing decisions and market
penetration. As the healthcare landscape continues to evolve, urine
output monitoring systems are poised to become indispensable tools
for healthcare professionals in optimizing patient care and
clinical outcomes.
Get a sneak peek at the urine output monitoring systems market
dynamics @ Urine Output Monitoring Systems Market Dynamics
Analysis
Report
Metrics
|
Details
|
Coverage
|
Global
|
Study Period
|
2021–2030
|
Urine Output Monitoring
Systems Market CAGR
|
~5%
|
Key Urine Output
Monitoring Systems Companies
|
BD, Potrero Medical
Inc., 3i Group plc, Serenno Medical, RenalSense Ltd., FIZE Medical,
among others
|
Urine Output Monitoring Systems Market Assessment
- Urine Output Monitoring Systems Market Segmentation
-
- Urine Output Monitoring Systems Market Segmentation By
Product Type: Manual Urine Output Monitoring Systems and
Automated Urine Output Monitoring Systems
- Urine Output Monitoring Systems Market Segmentation By
Usage: Disposable and Reusable
- Urine Output Monitoring Systems Market Segmentation By End
User: Hospital, Specialty Clinics, and Others
- Urine Output Monitoring Systems Market Segmentation By
Geography: North America,
Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case
Studies, KOL's Views, Analyst's View
Which MedTech key players in the urine output monitoring systems
market are set to emerge as the trendsetter explore @ Urine
Output Monitoring Systems Companies
Table of Contents
1
|
Report
Introduction
|
2
|
Executive
summary
|
3
|
Regulatory and Patent
Analysis
|
4
|
Key Factors
Analysis
|
5
|
Porter's Five Forces
Analysis
|
6
|
Urine Output Monitoring
Systems Market Layout
|
7
|
Global Company Share
Analysis – Key 3-5 Companies
|
8
|
Urine Output Monitoring
Systems Market Company and Product
Profiles
|
9
|
Project
Approach
|
10
|
About
DelveInsight
|
Interested in knowing the urine output monitoring systems market
by 2030? Click to get a snapshot of the Urine Output
Monitoring Systems Market Trends
Related Reports
Chronic Kidney Disease Market
Chronic Kidney Disease Market Insight, Competitive Landscape,
and Market Forecast – 2034 report delivers an in-depth
understanding of market trends, market drivers, market barriers,
and key CKD companies, including ProKidney, Reata
Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli
Lilly and Company, KBP Biosciences, Kibow Pharma, Cincor Pharma,
AstraZeneca, Allena Pharmaceuticals, DiaMedica Therapeutics Inc,
Lexicon Pharmaceuticals, Sanofi, among others.
Chronic Kidney Disease Pipeline
Chronic Kidney Disease Pipeline Insight –
2024 report provides comprehensive insights about the
pipeline landscape, pipeline drug profiles, including clinical and
non-clinical stage products, and the key chronic kidney
disease companies, including KBP Biosciences, Eli Lilly and
Company, Novo Nordisk, Prokidney, Boryung Pharmaceutical, among
others.
Moderate and Severe Chronic Kidney Disease Market
Moderate and Severe Chronic Kidney Disease Market Insights,
Epidemiology, and Market Forecast – 2032 report
delivers an in-depth understanding of the disease, historical and
forecasted epidemiology, as well as the market trends, market
drivers, market barriers, and key moderate and severe chronic
kidney disease companies, including Kibow Pharma, Bayer,
Roche, Caladrius Biosciences, UnicoCell Biomed, Pharmicell, Scohia
Pharma, Unicycive Therapeutics, among others.
Moderate and Severe Chronic Kidney Disease Pipeline
Moderate and Severe Chronic Kidney Disease Pipeline
Insight – 2024 report provides comprehensive insights
about the pipeline landscape, pipeline drug profiles, including
clinical and non-clinical stage products, and the key moderate
and severe chronic kidney disease companies, including
Kibow Pharma, Bayer, Roche, Caladrius Biosciences,
UnicoCell Biomed, Pharmicell, Scohia Pharma, Unicycive
Therapeutics, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports
pharma companies by providing comprehensive end-to-end solutions to
improve their performance.
Contact Us
Shruti
Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo:
https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/global-urine-output-monitoring-systems-market-is-projected-to-grow-at-a-cagr-of-5-by-2030--delveinsight-302126998.html